Human tPA enzyme-linked immunoassay kit(one step)

CAT: EHY0158 Datasheet
Specification 96 Test
Sensitivity 0.03 ng/ml (50 μl);0.10 ng/ml (10 μl);
Standard Curve Range 0.14~100 ng/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Sample Volume 50 μl/10 μl
Type Fully Ready-to-Use
Operation Duration 60min
ng/ml O.D. Average Corrected
0.00 0.0058 0.0064 0.0061
0.14 0.0107 0.0096 0.0102 0.0041
0.41 0.0195 0.0181 0.0188 0.0127
1.23 0.0457 0.0450 0.0454 0.0393
3.70 0.1406 0.1261 0.1334 0.1273
11.11 0.4191 0.3776 0.3984 0.3923
33.33 1.1900 1.1700 1.1800 1.1739
100.00 2.8370 2.8780 2.8575 2.8514

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(ng/ml) 1.8 9.0 29.2 1.8 9.4 31.7
Standard Deviation 0.1 0.4 1.5 0.1 0.4 1.8
Coefficient of Variation(%) 5.7 4.6 5.1 5.2 3.9 5.6

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.

Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of human tPA into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 97% to 115% with an overall mean recovery of 104%.

Sample Values

Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Serum 30 3.24-20.65 100 9.25

Serum/Plasma – Thirty samples from apparently healthy volunteers were evaluated for the presence of tPA in this assay. No medical histories were available for the donors.

Background: PAI-1/Serpin E1

PLAT, also known as tissue-type plasminogen activator (tPA), is a secreted serine protease synthesized by endothelial cells (1). The partially active single chain can be further processed to full activity by plasmin, tissue kallikrein or Factor Xa. Active PLAT converts plasminogen to plasmin, a fibrinolytic protease, by hydrolyzing an Arg-Val peptide bond in plasminogen. Unusually high levels of tPA activity can result in excessive bleeding, and low levels of tPA activity can result in thrombosis or embolism. Human PLAT contains 4 domains; the N-terminal fibronectin type-1 domain, an epidermal growth factor-like domain, two kringle domains and a serine protease catalytic domain.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee